Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).

Saved in:
Bibliographic Details
Title: Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
Authors: De Grève J; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Van Meerbeeck J; Department of Thoracic Oncology, University Hospital, Gent, Belgium., Vansteenkiste JF; Department of Pneumology, University Hospital KU Leuven, Leuven, Belgium., Decoster L; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Meert AP; Department of Pneumology, Institut Jules Bordet, Brussels, Belgium., Vuylsteke P; Department of Medical Oncology, Clinique et Maternité Sainte-Elisabeth, Namur, Belgium., Focan C; Department of Medical Oncology, CHC Clinique Saint Joseph, Liège, Belgium., Canon JL; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium., Humblet Y; Department of Medical Oncology, Centre du Cancer de l'Université Catholique de Louvain, Brussels, Belgium., Berchem G; Department of Medical Oncology, Centre Hospitalier du Luxembourg, Luxembourg, Luxembourg., Colinet B; Department of Medical Oncology, Grand Hôpital de Charleroi, Charleroi, Belgium., Galdermans D; Department of Medical Oncology, ZNA Middelheim Hospital, Antwerp, Belgium., Bosquée L; Department of Respiratory Medicine, CHU Sart-Tilman, Liège, Belgium., Vermeij J; Department of Medical Oncology, ZNA Jan Palfijn, Merksem, Belgium., Dewaele A; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Geers C; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Schallier D; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium., Teugels E; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Brussels, Belgium.
Source: PloS one [PLoS One] 2016 Mar 31; Vol. 11 (3), pp. e0147599. Date of Electronic Publication: 2016 Mar 31 (Print Publication: 2016).
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0147599